CR9857A - Composiciones de suplemento de hierro con tolerancia mejorada - Google Patents

Composiciones de suplemento de hierro con tolerancia mejorada

Info

Publication number
CR9857A
CR9857A CR9857A CR9857A CR9857A CR 9857 A CR9857 A CR 9857A CR 9857 A CR9857 A CR 9857A CR 9857 A CR9857 A CR 9857A CR 9857 A CR9857 A CR 9857A
Authority
CR
Costa Rica
Prior art keywords
iron
improved tolerance
supplement compositions
iron supplement
effective amount
Prior art date
Application number
CR9857A
Other languages
English (en)
Inventor
Krebs Peter
Kreb-Bensch Allison
Mincy Jerome
Original Assignee
Grace Procurements Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37902204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9857(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grace Procurements Llc filed Critical Grace Procurements Llc
Publication of CR9857A publication Critical patent/CR9857A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a las composiciones y metodos para el tratamiento o profilaxis de la deficiencia de hierro, y en particular, de la anemia causada por la deficiencia de hierro, mediante la administracion de una composicion que contiene una cantidad eficaz de una sal de hierro ferrosa farmaceuticamente aceptable, y una cantidad eficaz de un complejo de polisacarido de hierro.
CR9857A 2005-10-04 2008-04-01 Composiciones de suplemento de hierro con tolerancia mejorada CR9857A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/243,043 US20070077313A1 (en) 2005-10-04 2005-10-04 Toleration iron supplement compositions

Publications (1)

Publication Number Publication Date
CR9857A true CR9857A (es) 2008-07-29

Family

ID=37902204

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9857A CR9857A (es) 2005-10-04 2008-04-01 Composiciones de suplemento de hierro con tolerancia mejorada

Country Status (10)

Country Link
US (2) US20070077313A1 (es)
EP (1) EP1945032A4 (es)
CA (1) CA2624619C (es)
CR (1) CR9857A (es)
CU (1) CU23776B7 (es)
EC (1) ECSP088348A (es)
HN (1) HN2008000582A (es)
SV (1) SV2009002862A (es)
TW (1) TWI358299B (es)
WO (1) WO2007044180A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
WO2007117706A2 (en) * 2006-04-07 2007-10-18 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
CN102046192B (zh) * 2008-05-07 2014-11-19 默里昂研究Ⅲ有限公司 GnRH相关化合物的组合物及制备方法
WO2010099255A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
WO2012094598A2 (en) * 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
CN102167752B (zh) * 2011-05-23 2012-08-08 华南理工大学 一种水溶性大豆多糖亚铁配合物的制备方法
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
WO2022198329A1 (en) * 2021-03-26 2022-09-29 Alberta Veterinary Laboratories Ltd. Water-based iron supplement formulations for dosing animal neonates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
US6599498B1 (en) * 1999-04-09 2003-07-29 Advanced Magnetics, Inc. Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives
US20030190355A1 (en) * 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
CA2495564A1 (en) * 2002-08-15 2005-01-27 Euro-Celtique S.A. Pharmaceutical compositions
EP1735056B1 (en) * 2004-03-19 2012-10-24 Warner Chilcott Company, LLC Extended cycle multiphasic oral contraceptive method
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia

Also Published As

Publication number Publication date
CU20080054A7 (es) 2010-08-30
SV2009002862A (es) 2009-01-27
CU23776B7 (es) 2012-02-15
EP1945032A2 (en) 2008-07-23
US20110052722A1 (en) 2011-03-03
WO2007044180A2 (en) 2007-04-19
EP1945032A4 (en) 2009-04-15
CA2624619C (en) 2018-03-13
TWI358299B (en) 2012-02-21
HN2008000582A (es) 2011-11-09
CA2624619A1 (en) 2007-04-19
WO2007044180A3 (en) 2007-07-12
ECSP088348A (es) 2008-07-30
US20070077313A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
CU20080054A7 (es) Composiciones con suplemento de hierro con tolerancia mejorada
PE20061122A1 (es) Composiciones que incluyen hierro
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
BR112015018663A2 (pt) derivados de piridazinona-amidas
UA103614C2 (uk) Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки
CR10680A (es) Composiciones de inhibidores de chk1
SMT201300096B (it) Inibitori di prolil idrossilasi
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CR11418A (es) Trans-clomifeno para el sindrome metabolico
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
AR050717A1 (es) Composiciones farmaceuticas
AR089269A1 (es) Composiciones para el cuidado oral
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
AR062248A1 (es) Composiciones y metodos para tratar artritis reumatoidea
TW200700071A (en) Novel use
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
TW200726460A (en) Anti-fatigue composition
HN2008001531A (es) Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia
GT200900139A (es) Metodos para el tratamiento del abuso, adiccion y dependencia del alcohol
MX2010004859A (es) Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.
AR088600A1 (es) Composiciones de yodo-povidona
CA2610046A1 (en) Antimicrobial composition useful for preserving wood
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion